Male scientists in the United Kingdom report teaching less than their female counterparts, while women and minorities tend to feel disadvantaged in their careers.

Linguists, anthropologists and political scientists take to Capitol Hill to defend their research.

Critics of the March for Science have a point. But those scientists who will protest and speak up globally for research have the chance to make a greater one.

Highly anticipated independent review also calls for better oversight and coordination of government research spending.

Academics protest over government's 'dual use' research programme — which received a big funding boost.

US Food and Drug Administration says firm can provide consumers with information on genetic risks.

Cheap, stripped-down microcontrollers are allowing users to pack huge amounts of computing power into tiny spaces.

New tool joins a growing collection of software for accessing fee-for-view scientific literature.

After years of austerity, researchers fear that the latest dramatic cut will destroy the country's science.

Funnel plots are a popular tool in spotting when scientists in a field leave out negative study results, but one researcher says the method is flawed.

Papers from 2015 are a tougher read than some from the nineteenth century — and the problem isn't just about words, says Philip Ball.

More than 30% of biomedical studies funded by the US government are later cited in commercial patents.

An analysis of more than 50 collaborations shows the secrets of success, write Joel Cutcher-Gershenfeld and colleagues from the Stakeholder Alignment Collaborative.

Beleaguered institution cancels presidential election two days before vote, and appoints acting chief.

Global health charity is latest funder to start its own publishing ‘channel’ — and the European Commission is considering its own service.

Emphasis on innovation overshadowed by funding freeze for key research councils.

An investigation finds that dozens of academic titles offered 'Dr Fraud' — a sham, unqualified scientist — a place on their editorial board.

Yves Meyer wins the Abel Prize for role in theory with data applications from digital cinema to pinpointing gravitational waves.

Hundreds of researchers pick through clinical trial from a major blood-pressure study, to the dismay of some who collected the information.

Editors are more likely to select reviewers of the same gender.

Trump’s pick for the US regulatory agency will bring experience and a clear vision — as well as ties to industry.

Crippling the US National Institutes of Health might increase resistance to other attacks on science.

Popular leader will be forced to retire at 65 — but senior staff have other ideas.

The Environmental Protection Agency and the National Institutes of Health are big losers — but planetary science at NASA stands to gain.